Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-07T12:38:29.225Z Has data issue: false hasContentIssue false

A 6-year follow-up study of adult patients with congenitally corrected transposition

Published online by Cambridge University Press:  19 December 2014

Mirta Koželj*
Affiliation:
Department of Cardiology, University Medical Centre Ljubljana, Zaloška 7, 1525 Ljubljana, Slovenia Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia
Marta Cvijić
Affiliation:
Department of Cardiology, University Medical Centre Ljubljana, Zaloška 7, 1525 Ljubljana, Slovenia
Pavel Berden
Affiliation:
Institute of Radiology, University Medical Centre Ljubljana, Zaloška 7, 1525 Ljubljana, Slovenia Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia
Tomaž Podnar
Affiliation:
Department of Paediatrics, University Medical Centre Ljubljana, Zaloška 7, 1525 Ljubljana, Slovenia Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia
*
Correspondence to: Prof. Mirta Koželj, MD, Department of Cardiology, University Medical Centre Ljubljana, Zaloška 7, 1525 Ljubljana, Slovenia. Tel:+38 601 522 2844; Fax:+38 601 522 2828; E-mail: mirta.kozelj@mf.uni-lj.si
Rights & Permissions [Opens in a new window]

Abstract

The aims of this study were to assess the development of heart failure in patients with congenitally corrected transposition of the great arteries in a medium-term follow-up, to identify the impact of tricuspid regurgitation on the development of heart failure, and to determine the most reliable marker for its identification. The prospective 6-year follow-up study included 19 adult patients. All patients were evaluated clinically by the determination of N-terminal pro-hormone brain natriuretic peptide levels, exercise stress testing, echocardiography magnetic resonance, or CT. Among them, two patients died of heart failure. There was a decline in exercise capacity and systolic systemic ventricular function (p=0.011). Systemic ventricular ejection fraction decreased (48.3±13.7 versus 42.7±12.7%, p=0.001). Tissue Doppler imaging showed a decline in peak tricuspid systolic annular velocity (10.3±2.0 versus 8.3±2.5 cm/second, p=0.032) and peak tricuspid early diastolic annular velocity (14.6±4.3 versus 12.0±4.5 cm/second, p=0.048). The tricuspid regurgitation did not increase significantly. N-terminal pro-hormone brain natriuretic peptide levels increased (127.0 ng/L(82.3–305.8) versus 226.0 ng/L(112.5–753.0), p=0.022). Progressive exercise intolerance in congenitally corrected transposition of the great arteries appears to be driven mainly by a progression in systemic right ventricular dysfunction. Tricuspid regurgitation is likely to play a role, especially in patients with structural abnormalities of the tricuspid valve – Ebstein anomaly. The N-terminal pro-hormone brain natriuretic peptide levels and tissue Doppler parameters appear sensitive in detecting changes over time and may guide management.

Information

Type
Original Articles
Copyright
© Cambridge University Press 2014 
Figure 0

Table 1 Baseline clinical characteristics of congenitally corrected transposition of the great arteries patients.

Figure 1

Table 2 Echocardiographic parameters.

Figure 2

Figure 1 Correlation between the change in systolic tissue Doppler velocities at the septal side of the tricuspid annulus (Sm) and the change in systemic right ventricular ejection fraction as assessed by MRI/multi-slice CT (ρ=0.575, p=0.025).

Figure 3

Figure 2 Correlation between the change in diastolic tissue Doppler velocities at the septal side of the tricuspid annulus (Em) and the change in systemic right ventricular ejection fraction determined by MRI/multi-slice CT (ρ=0.629, p=0.012).

Figure 4

Figure 3 Correlation between the change in the average E/(mean Em, Et) ratio and the change in systemic right ventricular ejection fraction assessed by MRI/multi-slice CT (r=−0.606, p=0.022).